Mutations in cholesteryl ester transfer protein and hepatic lipase in a North American population

Clinical Biochemistry

Volumn 30, Issue 5, 1997, Pages 413-418

  Hill, Stephen A ^a,b   Nazir, Darius J ^a   Jayaratne, Padman ^a   Bamford, Karen S ^a   McQueen, Matthew J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

Cholesteryl ester; Hepatic lipase; Lipids; Lipoproteins; Mutations; Polymerase chain reaction

Indexed keywords

ARGININE; CHOLESTEROL ESTER TRANSFER PROTEIN; GLUTAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE;

AMINO ACID SUBSTITUTION; ARTICLE; FEMALE; GENE MUTATION; HUMAN; HYPERLIPOPROTEINEMIA; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NORTH AMERICA; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; LIPASE; LIVER; MALE; MUTATION; NORTH AMERICA; POLYMERASE CHAIN REACTION;

EID: 0031194895     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(97)00009-X     Document Type: Article

References (27)

1. 1. Castelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am J Med 1984; 76(2A): 4-12.
2. 2. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211-28.
3. 3. Lagrost L. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1994; 1215: 209-36.
4. 4. Tall AR. Plasma cholesteryl ester transfer protein and high density lipoproteins: New insights from molecular genetic studies. J Int Med 1995; 237: 5-12.
5. 5. Inazu A, Brown ML, Hesler CB, et al. Increased high density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Eng J Med 1990; 323: 1234-8.
6. 6. Inazu A, Koizumi J, Haraki T, et al. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia. Human Genetics 1993; 91: 13-16.
7. 7. Funke H, Wiebusch H, Fuer L, et al. Identification of mutations in the cholesterol ester transfer protein in Europeans with elevated high density lipoprotein cholesterol. Circulation, 1994; 90(Suppl 1): 241.
8. 8. Tamminen M, Kakko S, Kesäniemi A, Savolainen MJ. A polymorphic site in the 3′ untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity. Atherosclerosis 1996; 124: 237-47.
9. 9. Bensadoun A, Berryman DE. Genetics and molecular biology of hepatic lipase. Current Opin Lipidol 1996; 7: 77-81.
10. 10. Breckenridge WC, Little JA, Alaupovic P, et al. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis 1982; 45: 161-79.
11. 11. Connelly PW, Maguire GF, Lee M, Little JA. Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis 1990; 10: 40-8.
12. 12. Hegele RA, Vezina C, Moorganis, et al. A hepatic lipase gene mutation associated with heritable lipolytic deficiency. J Clin Endo Metab 1991; 72: 730-2.
13. 13. Auwerx JH, Babirak SP, Hokanson JE, et al. Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family. Am J Hum Genet 1990; 46: 470-7.
14. 14. Carlson LA, Holmquist L, Nilsson-Ehle P. Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-α-triglyceridemia. Acta Med Scand 1986; 219: 435-47.
15. 15. Knudsen P, Antikainen M, Ehnholm S, et al. A compound heterozygote for hepatic lipase gene mutations Leu 334 → Phe and T 383 → Met: Correlation between hepatic lipase activity and phenotype expression. J Lipid Res 1996; 37: 825-34.
16. 16. Sheriff DS, El Fakhri M, Ghivarska K. Libyian family with hypercholesterolemia and increased high density lipoprotein cholesterol in plasma. Clin Chem 1994; 42: 2313-16.
17. 17. Geisel J, Schleifenbaum T, Weißhaur B, Oette K. Improvement of detection of familial defective apolipoprotein B-100 by restriction site introducing PCR. Clin Chem 1993; 39: 2026-7.
18. 18. Takahashi K, Jiang X-C, Sakai N, et al. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest 1993; 92: 2060-4.
19. 19. Hadjeb N, Berkowitz GA. Preparation of T-overhang vectors with high PCR product cloning efficiency. Biotechniques 1996; 20: 20-2.
20. 20. Chung CT, Niemela SH, Miller RN. One-step purification of competent Esherichia coli: transformation and storage of bacterial cells in the same solution. Proc Nat Acad Sci USA 1989; 86: 2172-5.
21. 21. Zhang S, Sharp DS, Grove JS, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein despite increased HDL levels. J Clin Invest 1996; 97: 2917-23.
22. 22. Marotti KR, Castle CK, Boyle TP, et al. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993; 367: 73-5.
23. 23. Tall AR, Granot E, Tabas I, et al. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. J Clin Invest 1987; 79: 1217-25.
24. 24. Inazu A, Koczimi J, Mabuchi H, Kajinami K, Takeda R. Enhanced cholesteryl ester transfer protein activities and abnormalities of high desnity lipoproteins in familial hypercholesterolemia. Horm Metab Res 1992; 24: 284-8.
25. 25. Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia. J Clin Invest 1991; 87: 1259-65.
26. 26. Roy P, MacKenzie R, Hirama T, et al. Structure-function relationships of human cholesteryl ester transfer protein: analysis using monoclonal antibodies. J Lipid Res 1996; 37: 22-34.
27. 27. Hegele RA, Tu L, Connelly PW. Human hepatic lipase mutations and polymorphisms. Human Mutation 1992; 1: 320-4.